NCT06330883View on ClinicalTrials.gov

Determining the Prevalence of Frailty and Evaluating Its Relationship With Mortality.

CompletedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

January 1, 2023

Conditions
FrailtyMortalityCOVID-19
Interventions
DIAGNOSTIC_TEST

Prognosis

survival/mortalite

Trial Locations (1)

Unknown

Selcuk University Hospital, Konya

All Listed Sponsors
lead

Selcuk University

OTHER

NCT06330883 - Determining the Prevalence of Frailty and Evaluating Its Relationship With Mortality. | Biotech Hunter | Biotech Hunter